Skip to content

Comparison of gayatryadi ghanvati with oral hypoglycemic agent in the treatment of diabetes mellitus

A randomized controlled clinical trial to evaluate an adjuvant effect of gayatryadi ghanvati with oral hypoglycemic agent Glimepiride plus Metformin with special reference in diabetes mellitus type 2

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/07/034795
Enrollment
60
Registered
2021-07-13
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications Health Condition 2: E119- Type 2 diabetes mellitus without complications

Interventions

Intervention1: Glimepiride and Metformin: Group B 30 patients will be treated orally with Glimepiride and Metformin for 90 days Control Intervention1: gayatryadi ghanvati with Glimepiride and Metform

Sponsors

PDEAs College of Ayurveda And Research Centre Akurdi Pune
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: i. Patients of age between 35 to 70 years. ii. Patients who complains symptoms of diabetes mellitus. iii. Patients with fasting blood sugar upto 200mg and post prandial blood sugar upto 300mg

Exclusion criteria

Exclusion criteria: ii. Insulin dependent diabetes mellitus and those who are under insulin therapy. ii. Patient with acute complications like hyperglycemic and hypoglycemic coma, ketoacidosis iii. Patient having chronic complicationsuch as end stage renal disease and cardiac complication iv. Pregnant and lactating women

Design outcomes

Primary

MeasureTime frame
Primary outcome measure would be BSL (Blood sugar level) and HbA1c ( Glyacted Hemoglobin)Timepoint: Follow up on every 15th day for three times

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactDr Medha Mahesh Joshi

PDEAs College of Ayurveda And Research Centre Akurdi Pune

medhamaheshjoshi@gmail.com9881465798

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026